|
Soto, Ana M; Maffini, Maricel V; Schaeberle, Cheryl M et al. (2006) Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract Res Clin Endocrinol Metab 20:15-33
|
|
Geck, P; Maffini, M V; Szelei, J et al. (2000) Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. Proc Natl Acad Sci U S A 97:10185-90
|
|
Szelei, J; Soto, A M; Geck, P et al. (2000) Identification of human estrogen-inducible transcripts that potentially mediate the apoptotic response in breast cancer. J Steroid Biochem Mol Biol 72:89-102
|
|
Geck, P; Szelei, J; Jimenez, J et al. (1999) Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus. J Steroid Biochem Mol Biol 68:41-50
|
|
Soto, A M; Michaelson, C L; Prechtl, N V et al. (1998) Assays to measure estrogen and androgen agonists and antagonists. Adv Exp Med Biol 444:9-23;discussion 23-8
|
|
Sonnenschein, C; Soto, A M (1998) An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65:143-50
|
|
Geck, P; Szelei, J; Jimenez, J et al. (1997) Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells. J Steroid Biochem Mol Biol 63:211-8
|
|
Szelei, J; Jimenez, J; Soto, A M et al. (1997) Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138:1406-12
|
